SYK — Stryker Corporation stock price and chart

SYK

$301.42-1.54%

as of close, Oct 27, 2026

☾ AH $301.42 -1.54%

Stryker CorporationStock · HealthcareS&P 500 Equal Weight · 0.2% of RSPS&P 500 · 0.2% of SPYRussell 1000 · 0.2% of IWBUS Stock Market · 0.2% of VTIRussell 3000 · 0.1% of IWVMSCI World · 0.1% of URTHMSCI ACWI · 0.1% of ACWI

PeersMDTABTBSXEWSTEGEHC

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDED

20162019202120242026

150.0200.0250.0300.0350.0010.0M20.0M$301.42

2026-10-27

Price$301.42

MA20$307.95

MA50$338.69

Vol11.4M

What would $1,000 invested in SYK be worth today? →

SYK returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $301.42
YTD price return: -14.24%
YTD total return: -13.51%
Next earnings: Oct 29, 2026 · After close
Market cap: 115.6B2016-12 44.9B2026-10 115.7B+157.8% over the window
Enterprise value: 127.7B
Shares outstanding: 383.6M2016-06 374.3M2026-06 383.6M+2.5% over the window
52W low: $267.00
52W high: $389.33
From 52W high: -22.58%
From 52W low: +12.89%
52W range: 28%
Beta: 0.76

Volume

Rel volume: 0.87×
30D volume: 2.6M
30D $ vol: 744M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.: none
Insider net 1MNo open-market insider purchase or sale with a transaction date in the last 30 days, as filed on Form 4.: none
Insider net 3M0 insider-days of buying (no priced lot) and 4 of selling ($118.2M) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$118.2M
Insider net 1Y0 insider-days of buying (no priced lot) and 10 of selling ($400.8M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$400.8M

Form 4 transactions by trade date, as filed; latest on file 2026-08-21.

Fundamentals

Sales (ttm): 25.8B2016-06 10.5B2026-06 25.8B+146.8% over the window
Sales/share: $67.362016-06 $27.972026-06 $67.36+140.8% over the window
EPS (ttm): $9.652016-06 $4.242026-06 $9.65+127.6% over the window
FCF (ttm): 4.7B2016-06 614M2026-06 4.7B+665.8% over the window
FCF/share: $12.262016-06 $1.642026-06 $12.26+647.3% over the window
Book value/share: $62.542016-06 $24.312026-06 $62.54+157.3% over the window
Net margin: 14.43%2016-06 15.3%2026-06 14.4%-5.8% over the window
ROE: 15.55%2016-06 17.6%2026-06 15.5%-11.9% over the window
ROA: 7.78%2016-06 7.8%2026-06 7.8%-0.5% over the window
Debt / equity: 0.59×2016-06 0.742026-06 0.59-19.9% over the window
Current ratio: 2.162016-06 2.172026-06 2.16-0.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +8.48%2025-06-30 → 2026-06-3023.8B → 25.8B (+8.5% total)+9.92%2023-06-30 → 2026-06-3019.5B → 25.8B (+32.8% total)+9.72%2021-06-30 → 2026-06-3016.2B → 25.8B (+59.0% total)+9.45%2016-06-30 → 2026-06-3010.5B → 25.8B (+146.8% total)
Net income: +27.81%2025-06-30 → 2026-06-302.9B → 3.7B (+27.8% total)+11.24%2023-06-30 → 2026-06-302.7B → 3.7B (+37.7% total)+12.35%2021-06-30 → 2026-06-302.1B → 3.7B (+79.0% total)+8.80%2016-06-30 → 2026-06-301.6B → 3.7B (+132.3% total)
FCF: +16.86%2025-06-30 → 2026-06-304B → 4.7B (+16.8% total)+24.83%2023-06-30 → 2026-06-302.4B → 4.7B (+94.5% total)+9.60%2021-06-30 → 2026-06-303B → 4.7B (+58.2% total)+22.58%2016-06-30 → 2026-06-30614M → 4.7B (+665.8% total)
Shares: +0.33%2025-06-30 → 2026-06-30382.3M → 383.6M (+0.3% total)+0.33%2023-06-30 → 2026-06-30379.8M → 383.6M (+1.0% total)+0.34%2021-06-30 → 2026-06-30377.1M → 383.6M (+1.7% total)+0.25%2016-06-30 → 2026-06-30374.3M → 383.6M (+2.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +27.84%2025-06-30 → 2026-06-30$7.55 → $9.65 (+27.8% total)+10.87%2023-06-30 → 2026-06-30$7.08 → $9.65 (+36.3% total)+12.07%2021-06-30 → 2026-06-30$5.46 → $9.65 (+76.7% total)+8.57%2016-06-30 → 2026-06-30$4.24 → $9.65 (+127.6% total)
Sales/share: +8.12%2025-06-30 → 2026-06-30$62.30 → $67.36 (+8.1% total)+9.55%2023-06-30 → 2026-06-30$51.23 → $67.36 (+31.5% total)+9.35%2021-06-30 → 2026-06-30$43.08 → $67.36 (+56.4% total)+9.19%2016-06-30 → 2026-06-30$27.97 → $67.36 (+140.8% total)
FCF/share: +16.48%2025-06-30 → 2026-06-30$10.53 → $12.26 (+16.5% total)+24.42%2023-06-30 → 2026-06-30$6.36 → $12.26 (+92.6% total)+9.23%2021-06-30 → 2026-06-30$7.88 → $12.26 (+55.5% total)+22.28%2016-06-30 → 2026-06-30$1.64 → $12.26 (+647.3% total)
Book value/share: +12.83%2025-06-30 → 2026-06-30$55.43 → $62.54 (+12.8% total)+11.01%2023-06-30 → 2026-06-30$45.71 → $62.54 (+36.8% total)+11.28%2021-06-30 → 2026-06-30$36.65 → $62.54 (+70.6% total)+9.91%2016-06-30 → 2026-06-30$24.31 → $62.54 (+157.3% total)
Dividend/share: +4.82%2025-06-30 → 2026-06-30$3.32 → $3.48 (+4.8% total)+5.72%2023-06-30 → 2026-06-30$2.95 → $3.48 (+18.2% total)+7.14%2021-06-30 → 2026-06-30$2.47 → $3.48 (+41.2% total)+8.89%2016-06-30 → 2026-06-30$1.48 → $3.48 (+134.3% total)
Price: -21.46%2025-10-27 → 2026-10-27$383.72 → $301.42 (-21.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+4.79%2023-10-27 → 2026-10-27$261.91 → $301.42 (+15.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+2.34%2021-10-27 → 2026-10-27$268.50 → $301.42 (+12.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+10.62%2016-10-26 → 2026-10-27$109.89 → $301.42 (+174.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -20.59%2025-10-27 → 2026-10-27$379.52 → $301.42 (-20.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+5.83%2023-10-27 → 2026-10-27$254.27 → $301.42 (+18.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+3.43%2021-10-27 → 2026-10-27$254.71 → $301.42 (+18.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+11.84%2016-10-26 → 2026-10-27$98.40 → $301.42 (+206.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 31.2×2016-12 27.042026-10 31.01+14.7% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 20.9×2016-12 20.842026-10 20.90+0.3% over the window
Fwd P/E: 18.4×
P/S (ttm)Market cap ÷ TTM revenue.: 4.5×2016-12 4.122026-10 4.48+8.6% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 4.8×2016-12 4.812026-10 4.82+0.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 24.6×2016-12 28.322026-10 24.60-13.2% over the window
EV/EBITDA (fy): 17.8×
EV/Sales (ttm): 4.9×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.07%2016-09 3.5%2026-06 3.9%+10.6% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 1.17%
Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only when the record holds that full cycle and it agrees with the dividends the company reports paying; otherwise —.: 1.17%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $3.52
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 383.6M ÷ 382.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.33%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.33%) + dividends paid over that year ($1.3B) ÷ market_cap_at(2025-06-30) ($151.3B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 0.54%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($115.6B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-09 0.6%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $1.3B) ÷ today's market cap ($115.6B). Same caveat as the cash buyback yield.: 1.14%2016-09 1.8%2026-06 1.1%-40.4% over the window

Vs own 10Y history

P/E: 19th
P/OI: 4th
P/S: 13th
P/B: 5th
P/FCF: 1st

Bar = where today’s multiple sits in SYK’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-27#

-1.54%

-0.98%

+10.67%

-10.49%

YTD

-14.24%

-21.45%

+12.26%

Recent filings#

Oct 68-K · Stryker announces leadership succession
Aug 21Insider sale · Crotty Dylan Bram (Group President) sold 441 shares for $145K at $328.61
Aug 19Insider sale · STRYKER RONDA E (Director) sold 350,000 shares for $117.8M on 2 days since Aug 18
Aug 18Insider sale · King Debra (See Remarks) sold 826 shares for $278K at $336.30
Jul 30Earnings · Earnings release — EPS $3.69 vs $3.46 est. (+6.7%); revenue $6.59B (+9% y/y) 6.4%

All filings and insider trades →

Financial statements

Open full SYK financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+8.32%	+0.22%
JNJ	Johnson & Johnson	-0.92%	+0.91%
ABBV	AbbVie Inc.	+8.34%	-0.12%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+8.98%	-0.08%
MRK	Merck & Co. Inc.	-4.68%	+0.86%
NVS	Novartis AG	+7.84%	+1.98%
TMO	Thermo Fisher Scientific Inc.	+2.67%	+1.19%
AMGN	Amgen Inc.	+8.04%	+0.75%

SYK — Stryker Corporation price, chart and key statistics